Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 27,593 $ 25,218
Marketable securities, current 141,783 68,667
Prepaid expenses 7,623 6,080
Accounts receivable, related party 0 234
Other current assets 445 1,125
Total current assets 177,444 101,324
Marketable securities, non-current 6,013 0
Operating lease right-of-use assets 9,002 11,104
Property and equipment, net 20,451 22,254
Other assets 5,019 5,195
Total assets 217,929 139,877
Current liabilities:    
Accounts payable 1,311 2,350
Accrued liabilities 11,305 12,575
Deferred revenue, current 32,240 14,014
Deferred revenue, current, related party 0 789
Other current liabilities, related party 0 5,614
Other current liabilities 2,541 2,211
Total current liabilities 47,397 37,553
Deferred revenue, long-term 51,302 4,538
Deferred revenue, long-term, related party 0 3,106
Long-term debt, net of current portion 35,251 14,926
Operating lease liabilities 10,284 12,213
Other liabilities, related party 0 6,711
Other liabilities 1,590 1,490
Total liabilities 145,824 80,537
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at June 30, 2021 and December 31, 2020; issued and outstanding: 250 shares at June 30, 2021 and December 31, 2020 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at June 30, 2021 and December 31, 2020; issued and outstanding: 56,138,404 shares at June 30, 2021 and 49,984,333 shares at December 31, 2020 56 50
Additional paid-in capital 413,857 328,314
Accumulated other comprehensive income, (loss) (1) 17
Accumulated deficit (341,807) (269,041)
Total stockholders’ equity 72,105 59,340
Total liabilities and stockholders’ equity $ 217,929 $ 139,877